Skip to main content

Irinotecan Hydrochloride

NDC 50742-402 · Ingenus Pharmaceuticals, LLC

Generic nameIrinotecan Hydrochloride
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)IRINOTECAN HYDROCHLORIDE
Strength100 mg/5mL
Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
Marketing categoryANDA

Packages

50742-402-05 — 1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL, GLASS

Billed under HCPCS

J9206 — Injection, irinotecan, 20 mg Medicare Part B payment limit (ASP + 6%): $1.85

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0009-7529 — irinotecan hydrochloride, 0143-9583 — Irinotecan Hydrochloride, 0143-9701 — Irinotecan Hydrochloride, 0143-9702 — Irinotecan Hydrochloride, 15054-0043 — IRINOTECAN HYDROCHLORIDE, 16714-027 — Irinotecan hydrochloride, 16714-131 — Irinotecan hydrochloride, 25021-230 — irinotecan hydrochloride, 45963-614 — Irinotecan hydrochloride, 50742-401 — Irinotecan Hydrochloride, 55150-352 — IRINOTECAN HYDROCHLORIDE, 55150-353 — IRINOTECAN HYDROCHLORIDE, 55150-354 — IRINOTECAN HYDROCHLORIDE, 55150-355 — IRINOTECAN HYDROCHLORIDE, 60505-6128 — Irinotecan Hydrochloride, 60505-6272 — Irinotecan Hydrochloride, 61703-349 — Irinotecan Hydrochloride, 63323-193 — IRINOTECAN HYDROCHLORIDE, 67184-0511 — Irinotecan Hydrochloride, 67184-0512 — Irinotecan Hydrochloride, +8 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.